Leyshon C - Search Results

1

Davies T, Cowley A, Bennie J, Leyshon C, Inger R, Carter H, Robinson B, Duffy JP, Casalegno S, Lambert G, Gaston K. Davies T, et al. Among authors: leyshon c. PLoS One. 2019 Feb 6;14(2):e0212101. doi: 10.1371/journal.pone.0212101. eCollection 2019. PLoS One. 2019. PMID: 30726304 Free PMC article.

2

Davies T, Cowley A, Bennie J, Leyshon C, Inger R, Carter H, Robinson B, Duffy J, Casalegno S, Lambert G, Gaston K. Davies T, et al. Among authors: leyshon c. PLoS One. 2018 Sep 26;13(9):e0203694. doi: 10.1371/journal.pone.0203694. eCollection 2018. PLoS One. 2018. PMID: 30256838 Free PMC article.

3

Fostering Engagement With Health and Housing Innovation: Development of Participant Personas in a Social Housing Cohort.

Williams AJ, Menneer T, Sidana M, Walker T, Maguire K, Mueller M, Paterson C, Leyshon M, Leyshon C, Seymour E, Howard Z, Bland E, Morrissey K, Taylor TJ. Williams AJ, et al. Among authors: leyshon c. JMIR Public Health Surveill. 2021 Feb 16;7(2):e25037. doi: 10.2196/25037. JMIR Public Health Surveill. 2021. PMID: 33591284 Free PMC article.

4

Improving health and wellbeing through social prescribing.

Mittal R, Rowse E, Leyshon M, Leyshon C. Mittal R, et al. Among authors: leyshon c. Br J Hosp Med (Lond). 2023 Jul 2;84(7):1-4. doi: 10.12968/hmed.2023.0121. Epub 2023 Jul 4. Br J Hosp Med (Lond). 2023. PMID: 37490444 Free article.

5

Corticosteroids as graft-versus-host disease prophylaxis for allogeneic hematopoietic cell transplant recipients with calcineurin inhibitor intolerance.

Puckrin R, Kwan ACF, Blosser N, Leyshon C, Duggan P, Daly A, Zepeda V, Stewart D, Chaudhry A, Storek J, Jamani K. Puckrin R, et al. Among authors: leyshon c. Cytotherapy. 2023 Oct;25(10):1101-1106. doi: 10.1016/j.jcyt.2023.05.010. Epub 2023 Jun 10. Cytotherapy. 2023. PMID: 37306643

6

Automated referral to community paramedicine during 9-1-1 fall calls for resource activation.

Quatman CE, Wiseman JM, Sheridan E, Caterino JM, Weade M, Wisner D, Leyshon C, Quatman-Yates C. Quatman CE, et al. Among authors: leyshon c. J Am Geriatr Soc. 2022 Dec;70(12):3578-3584. doi: 10.1111/jgs.18011. Epub 2022 Aug 30. J Am Geriatr Soc. 2022. PMID: 36039856 Free PMC article.

7

Toward optimization of cyclosporine concentration target to prevent acute graft-versus-host disease following myeloablative allogeneic stem cell transplant.

Kwan ACF, Blosser N, Ghosh S, Leyshon C, Dersch-Mills D, Puckrin R, Duggan P, Zepeda V, Savoie L, Stewart D, Storek J, Jamani K. Kwan ACF, et al. Among authors: leyshon c. Clin Transplant. 2022 Aug;36(8):e14732. doi: 10.1111/ctr.14732. Epub 2022 Jun 2. Clin Transplant. 2022. PMID: 35606904

8

Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKI.

Ma CE, Ghosh S, Leyshon C, Blosser N, Dersch-Mills D, Jupp J, Savoie L, Liew E, Jamani K. Ma CE, et al. Among authors: leyshon c. Leuk Res. 2021 Dec;111:106674. doi: 10.1016/j.leukres.2021.106674. Epub 2021 Jul 24. Leuk Res. 2021. PMID: 34333277

9

Incidence of late onset neutropenia associated with rituximab use in B cell lymphoma patients undergoing autologous stem cell transplantation.

Ha VH, Ghosh S, Leyshon C, Ryan N, Chambers CR, Stewart DA. Ha VH, et al. Among authors: leyshon c. J Oncol Pharm Pract. 2018 Jul;24(5):323-331. doi: 10.1177/1078155217702214. Epub 2017 Mar 30. J Oncol Pharm Pract. 2018. PMID: 28358279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters